Dapagliflozin reduced the primary composite outcome (sustained 50% eGFR decline, ESKD, or death from renal or cardiovascular causes) by 39% compared to placebo [47]
And when it disappears, your metabolism slows, your results stall, and the weight comes back faster than it left
Initially adaptive, this hyperfiltration response compensates for declining nephron mass but eventually exacerbates glomerular damage
However, the onset of generic competition will likely significantly reduce the price, and this means the NHS can afford to treat more patients
By improving systemic insulin sensitivity, semaglutide also attenuates adipose tissue lipolysis, thereby lowering the circulation of free fatty acids (FFAs) that would otherwise be delivered to the liver for TG synthesis [16]